[go: up one dir, main page]

DE69840024D1 - Antimikrobielle Peptide, abstammend von Ubiquicidin - Google Patents

Antimikrobielle Peptide, abstammend von Ubiquicidin

Info

Publication number
DE69840024D1
DE69840024D1 DE69840024T DE69840024T DE69840024D1 DE 69840024 D1 DE69840024 D1 DE 69840024D1 DE 69840024 T DE69840024 T DE 69840024T DE 69840024 T DE69840024 T DE 69840024T DE 69840024 D1 DE69840024 D1 DE 69840024D1
Authority
DE
Germany
Prior art keywords
ubiquicidine
ubiquicidin
instance
peptides derived
antimicrobial peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69840024T
Other languages
English (en)
Inventor
Petrus Hendricus Nibbering
Pieter Sicco Hiemstra
Maria Theodora Van D Barselaar
Ernest Karel Pauwels
Rolf Ide Feitsma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Leiden
Original Assignee
Universiteit Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Leiden filed Critical Universiteit Leiden
Application granted granted Critical
Publication of DE69840024D1 publication Critical patent/DE69840024D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
DE69840024T 1997-05-29 1998-05-29 Antimikrobielle Peptide, abstammend von Ubiquicidin Expired - Lifetime DE69840024D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1006164A NL1006164C2 (nl) 1997-05-29 1997-05-29 Antimicrobiële peptiden.
PCT/NL1998/000311 WO1998054314A1 (en) 1997-05-29 1998-05-29 Antimicrobial peptides derived from ubiquicidine

Publications (1)

Publication Number Publication Date
DE69840024D1 true DE69840024D1 (de) 2008-10-30

Family

ID=19765050

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69840024T Expired - Lifetime DE69840024D1 (de) 1997-05-29 1998-05-29 Antimikrobielle Peptide, abstammend von Ubiquicidin

Country Status (8)

Country Link
US (1) US6884776B1 (de)
EP (1) EP1003854B1 (de)
AT (1) ATE408685T1 (de)
AU (1) AU7791398A (de)
CA (1) CA2291894A1 (de)
DE (1) DE69840024D1 (de)
NL (1) NL1006164C2 (de)
WO (1) WO1998054314A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7603239B2 (en) * 2004-05-05 2009-10-13 Massachusetts Institute Of Technology Methods and systems for generating peptides
CN101111256B (zh) 2004-12-15 2012-04-25 科罗拉多大学 抗菌肽及其使用方法
CA2739842A1 (en) * 2008-10-06 2010-04-15 The Regents Of The University Of Colorado, A Body Corporate Antimicrobial peptides and methods of use
EP2204377A1 (de) * 2008-12-30 2010-07-07 Commissariat à l'énergie atomique et aux énergies alternatives Cysteinfreie, Technetium- oder Rhenium-chelatisierende Peptidsequenzen und deren Verwendung
WO2010141760A2 (en) * 2009-06-05 2010-12-09 The Regents Of The University Of Colorado, A Body Corporate Antimicrobial peptides
EP3384938A1 (de) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Manipulierte nukleinsäuren und verfahren zur verwendung davon
EP2847329A4 (de) 2012-04-02 2016-08-10 Moderna Therapeutics Inc Modifizierte polynukleotide zur herstellung von zytoplasma- und zytoskelett-proteinen
CN104411338A (zh) 2012-04-02 2015-03-11 现代治疗公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
GB201420222D0 (en) * 2014-11-13 2014-12-31 Univ Edinburgh Molecular probes and methods using the same
GB201420221D0 (en) * 2014-11-13 2014-12-31 Univ Edinburgh Molecular probes and methods using the same
CA3004790A1 (en) 2015-11-10 2017-05-18 Visterra, Inc. Lipopolysaccharide binding antibody-antimicrobial peptide conjugates and uses thereof
CN110431150A (zh) 2017-01-18 2019-11-08 威特拉公司 抗体分子-药物偶联物及其用途
CA3178465A1 (en) 2020-04-03 2021-10-07 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
KR102569795B1 (ko) * 2021-05-03 2023-08-23 경상국립대학교산학협력단 강도다리에서 유래한 유비퀴틴 관련 신규 항균 펩티드 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3005943B2 (ja) * 1990-04-17 2000-02-07 マリンクロッド・インコーポレイテッド テクネチウム―９９ｍ錯化合物製造のための方法及びキット
JP3009498B2 (ja) * 1991-03-28 2000-02-14 日清製粉株式会社 脂質分解酵素阻害剤
JPH08176193A (ja) * 1994-12-23 1996-07-09 Soosei:Kk 長期増強誘導性ペプチド
US6319503B1 (en) * 1998-02-19 2001-11-20 Proteinix Company Heat shock fusion-based vaccine system

Also Published As

Publication number Publication date
AU7791398A (en) 1998-12-30
NL1006164C2 (nl) 1998-12-01
US6884776B1 (en) 2005-04-26
ATE408685T1 (de) 2008-10-15
WO1998054314A1 (en) 1998-12-03
EP1003854A1 (de) 2000-05-31
CA2291894A1 (en) 1998-12-03
EP1003854B1 (de) 2008-09-17

Similar Documents

Publication Publication Date Title
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
CY1106875T1 (el) Αντιγονικα πεπτιδια απο neisseria
ATE218579T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
DE69838143D1 (de) Antimikrobielle peptide
WO1995021919A3 (en) Protein having tpo activity
CY1108049T1 (el) Πεπτιδια με βαση την αλληλουχια της ανθρωπινης λακτοφερρινης και χρηση τους
SE9100799L (sv) Rekombinant derivat av human faktor viii
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
DE60313982D1 (de) Dimere von thrombinpeptidderivaten
DE69940927D1 (de) PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
DE68905097D1 (de) Peptid-molekuele, wirksam gegen gram-positive keime.
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
DE69623803D1 (de) Verwendung von KASEINFRAGMENTEn als WACHSTUMERFÖRDERer
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2004011638A3 (en) Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures
WO2002100897A3 (fr) Complexes moleculaires brca1/acc alpha, applications diagnostiques et therapeutiques
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
WO2003027274A3 (en) Purified polypeptides from pseudomonas aeruginosa
WO2004041856A3 (en) Crystal structures of bacterial inorganic pyrophosphatases

Legal Events

Date Code Title Description
8364 No opposition during term of opposition